Literature DB >> 33934687

Understanding drug resistance mechanisms in cholangiocarcinoma: assisting the clinical development of investigational drugs.

Jose Jg Marin1, Rocio Ir Macias1.   

Abstract

Entities:  

Keywords:  Biliary tract cancer; FGFR; cholangiocarcinoma; drug resistance; immunotherapy; liver cancer; pharmacoresistance; targeted therapy; tumor heterogeneity

Year:  2021        PMID： 33934687     DOI： 10.1080/13543784.2021.1916912

Source DB:  PubMed          Journal:  Expert Opin Investig Drugs        ISSN： 1354-3784            Impact factor:   6.206


× No keyword cloud information.
  3 in total

Review 1.  Role of molecular genetics in the clinical management of cholangiocarcinoma.

Authors:  N Normanno; E Martinelli; D Melisi; C Pinto; L Rimassa; D Santini; A Scarpa
Journal:  ESMO Open       Date:  2022-06-10

Review 2.  Impact of Alternative Splicing Variants on Liver Cancer Biology.

Authors:  Jose J G Marin; Maria Reviejo; Meraris Soto; Elisa Lozano; Maitane Asensio; Sara Ortiz-Rivero; Carmen Berasain; Matias A Avila; Elisa Herraez
Journal:  Cancers (Basel)       Date:  2021-12-21       Impact factor: 6.639

3.  Molecularly Guided Drug Repurposing for Cholangiocarcinoma: An Integrative Bioinformatic Approach.

Authors:  Simran Venkatraman; Brinda Balasubramanian; Pisut Pongchaikul; Rutaiwan Tohtong; Somchai Chutipongtanate
Journal:  Genes (Basel)       Date:  2022-01-29       Impact factor: 4.096
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.